Cautious Continued Use of Paclitaxel-Eluting Devices in PAD Patients
This activity was presented at VAM2020 as part of Invited Section 3: Current Controversies in Endovascular Therapy for PAD.
- Discuss the use of paclitaxel-eluting devices in PAD patients.
- Identify devices and alternative access for crossing CTOs.
- Address arterialization management for no-option CLTI patients.
The opinions or views expressed on the SVS OnDemand platform and the SVS Video Library are those of the faculty and do not necessarily reflect the opinions, recommendations, or endorsement of SVS. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of SVS faculty who are willing to share such information with colleagues. The SVS disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services and events.